Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2000-11-3
pubmed:abstractText
We and others have reported that IFN-alpha potentiates the apoptotic effects of TNF through a mechanism that is not understood. Because the nuclear transcription factors NF-kappaB and AP-1 have recently been reported to mediate anti-apoptosis and cell survival, we hypothesized that IFN-alpha potentiates the cytotoxic effects of TNF by suppressing TNF-induced activation of NF-kappaB and AP-1. We tested this hypothesis by pretreating human Jurkat T cells with IFN-alpha, which blocked TNF-induced activation of NF-kappaB and AP-1 in a time- and dose-dependent manner as determined by EMSA. IFN-alpha blocked TNF-induced phosphorylation and degradation of the inhibitor subunit of NF-kappaB, and suppressed NF-kappaB and AP-1 activation induced by various other inflammatory stimuli. NF-kappaB-dependent reporter gene expression activated by TNF, TNFR1, TNF receptor-associated factor 2, and NF-kappaB-inducing kinase was also abrogated by IFN-alpha pretreatment. The suppression of NF-kappaB and AP-1 correlated with the potentiation of TNF-induced cytotoxicity and caspase activation. Overall our results suggest that IFN-alpha potentiates the apoptotic effects of TNF possibly by suppressing NF-kappaB and AP-1 activation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Caspases, http://linkedlifedata.com/resource/pubmed/chemical/Ceramides, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/I-kappa B Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B p50 Subunit, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappaB inhibitor alpha, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor AP-1, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor RelA, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
165
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4927-34
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11046018-Apoptosis, pubmed-meshheading:11046018-Caspases, pubmed-meshheading:11046018-Ceramides, pubmed-meshheading:11046018-Cytotoxicity, Immunologic, pubmed-meshheading:11046018-DNA-Binding Proteins, pubmed-meshheading:11046018-Drug Synergism, pubmed-meshheading:11046018-Enzyme Activation, pubmed-meshheading:11046018-Gene Expression Regulation, pubmed-meshheading:11046018-Genes, Reporter, pubmed-meshheading:11046018-Humans, pubmed-meshheading:11046018-I-kappa B Proteins, pubmed-meshheading:11046018-Immunosuppressive Agents, pubmed-meshheading:11046018-Interferon-alpha, pubmed-meshheading:11046018-Jurkat Cells, pubmed-meshheading:11046018-Lipopolysaccharides, pubmed-meshheading:11046018-NF-kappa B, pubmed-meshheading:11046018-NF-kappa B p50 Subunit, pubmed-meshheading:11046018-Phosphorylation, pubmed-meshheading:11046018-Transcription Factor AP-1, pubmed-meshheading:11046018-Transcription Factor RelA, pubmed-meshheading:11046018-Transfection, pubmed-meshheading:11046018-Tumor Necrosis Factor-alpha
pubmed:year
2000
pubmed:articleTitle
IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis.
pubmed:affiliation
Cytokine Research Laboratory, Department of Bioimmunotherapy, MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't